[New data on cytoprotection in radiotherapy]

Strahlenther Onkol. 1999 Nov:175 Suppl 4:1.
[Article in German]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Amifostine / administration & dosage
  • Amifostine / adverse effects
  • Amifostine / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Carboplatin / therapeutic use
  • Combined Modality Therapy
  • Cytoprotection*
  • Double-Blind Method
  • Follow-Up Studies
  • Head and Neck Neoplasms / drug therapy
  • Head and Neck Neoplasms / radiotherapy*
  • Head and Neck Neoplasms / surgery
  • Humans
  • Pilot Projects
  • Placebos
  • Postoperative Care
  • Preoperative Care
  • Radiation-Protective Agents / administration & dosage
  • Radiation-Protective Agents / adverse effects
  • Radiation-Protective Agents / pharmacology*
  • Radiotherapy / adverse effects*
  • Randomized Controlled Trials as Topic
  • Stomatitis / etiology
  • Stomatitis / prevention & control
  • Time Factors
  • Xerostomia / etiology
  • Xerostomia / prevention & control

Substances

  • Antineoplastic Agents
  • Placebos
  • Radiation-Protective Agents
  • Carboplatin
  • Amifostine